| PRD_001254 | Name: | PL-2 | Formula: | C29 H45 N6 O9 P | Definition date: | 2014-11-19 | Last modified: | 2014-11-19 |
|
| PRD_002115 | Name: | (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-24-{(2R)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl}-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | Formula: | C69 H125 N13 O13 | Definition date: | 2014-11-12 | Last modified: | 2014-11-12 |
|
| PRD_001080 | Name: | Peptide inhibitor MPT-DPP-ARG-G-LEU-NH2 | Formula: | C20 H40 N9 O5 S | Definition date: | 2014-10-15 | Last modified: | 2014-10-15 |
|
| PRD_001191 | Name: | iCAL36(BRB-K-1) peptide | Formula: | C58 H86 Br N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001192 | Name: | iCAL36(TFA-K-1) peptide | Formula: | C53 H82 F3 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001193 | Name: | iCAL36(FLB-K-1) peptide | Formula: | C58 H86 F N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001194 | Name: | iCAL36(Ac-K-5) peptide | Formula: | C48 H86 N15 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001195 | Name: | iCAL36(Ac-K-4) peptide | Formula: | C54 H89 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001196 | Name: | iCAL36(Ac-K-3) peptide | Formula: | C55 H89 N16 O15 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001197 | Name: | iCAL36(Ac-K-1) peptide | Formula: | C53 H85 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
| PRD_001232 | Name: | Alpha-conotoxin ImI mutant | Formula: | C54 H84 N20 O15 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
| PRD_001251 | Name: | ACE-PHE-ALA-THR-ALA-0QE | Formula: | C22 H31 Cl N4 O6 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
| PRD_001252 | Name: | ACE-ILE-ALA-THR-ALA-0QE | Formula: | C19 H33 Cl N4 O6 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
| PRD_002092 | Name: | L-alanyl-3,5-dibromo-L-tyrosyl-L-alanine | Formula: | C15 H19 Br2 N3 O5 | Definition date: | 2014-07-08 | Last modified: | 2014-07-08 |
|
| PRD_001078 | Name: | Peptide inhibitor MPT-DPP-DAR-G-DPN-NH2 | Formula: | C23 H38 N9 O5 S | Definition date: | 2014-06-25 | Last modified: | 2014-06-25 |
|
| PRD_001181 | Name: | GE23077 | Formula: | C31 H49 N9 O16 | Definition date: | 2014-05-07 | Last modified: | 2014-05-07 |
|
| PRD_001216 | Name: | Somatostatin-14 | Formula: | C76 H108 N18 O19 S2 | Definition date: | 2014-05-07 | Last modified: | 2014-05-07 |
|
| PRD_001229 | Name: | anti-CmABCB1 peptide | Formula: | C100 H139 N24 O26 S | Definition date: | 2014-04-30 | Last modified: | 2014-04-30 |
|
| PRD_001086 | Name: | Microviridin J | Formula: | C80 H108 N19 O22 | Definition date: | 2014-04-02 | Last modified: | 2014-04-02 |
|
| PRD_001218 | Name: | Dityromycin | Formula: | C67 H88 N10 O16 | Description: | DITYROMYCIN WAS CLARIFIED TO BE COMPOSED OF N-MEVAL, PRO, VAL, PHENYLGLYCINE, CH3NH2, N,N-ME2THR AND DI-ALPHA-AMINO ACID CONTAINING DIPHENYLETHER MOIETY. | Definition date: | 2014-04-02 | Last modified: | 2014-04-02 |
|
| PRD_001142 | Name: | tyrocidine A | Formula: | C66 H87 N13 O13 | Definition date: | 2014-03-19 | Last modified: | 2014-03-19 |
|
| PRD_001104 | Name: | cyclic peptide S2iL5 | Formula: | C90 H126 F3 N27 O23 S | Definition date: | 2014-02-19 | Last modified: | 2014-02-19 |
|
| PRD_001185 | Name: | CONANTOKIN BK-B | Formula: | C46 H64 N10 O25 | Definition date: | 2014-02-19 | Last modified: | 2014-02-19 |
|
| PRD_001167 | Name: | bicyclic peptide UK811 | Formula: | C74 H119 N26 O22 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|
| PRD_001168 | Name: | bicyclic peptide UK903 | Formula: | C72 H103 N19 O19 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|